Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ECMO Hemostatic Transfusions in Children

NCT05796557 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT05796557
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05796557 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ECMO Hemostatic Transfusions in Children
Lead sponsor
Yale University
Phase
Phase 4
Overall status
Completed
Start date
December 12, 2023
Completion date
March 25, 2025
Enrollment
50 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

extracorporeal membrane oxygenation complication, hemorrhage, thromboembolism, transfusion adverse reaction